Marios Georgakis: Largest GWAS of Transient Ischemic Attacks Reveals New Genetic Insights into Stroke Risk
Marios Georgakis, Research Group Leader and Physician at LMU Munich, Visiting Scientist at Broad Institute of MIT and Harvard University, shared on LinkedIn about a recent article by Shuyuan Hu et al, published in medRxiv, adding:
”Transient ischemic attacks (TIA) have been recognized since the 1950s as precursors of ischemic stroke and are treated accordingly.
We now have the largest GWAS for TIA, including 82,533 cases and 1,860,329 controls.
The study detected 44 loci, 25 of which have been previously associated with stroke or stroke subtypes.
The 19 ones not associated with stroke have largely been associated with vascular risk factors (mainly hypertension) or other manifestations of cardiovascular disease (e.g. coronary artery disease).
As expected, there were quite strong genetic correlations with all ischemic stroke subtypes, re-confirming the vascular origins of TIA, which for many patients remain unclear.
It is a great resource, as TIA can now be included as an outcome in genomic studies assessing drug target potential and secondary analyses of genetic signals related to vascular biology.
The summary stats can be useful for refining polygenic scores for stroke.”
Title: Genome-wide association study highlights 44 loci for transient ischemic attack and shared genetic architecture with stroke
Authors: Shuyuan Hu, Ping Zhu, Shiyang Wu, Shan Gao, Ruibai Wang, Fengzhen Liu, Yijie He, Zhifa Han, Tao Wang, Mingxin Wang, Changhong Ren, Xunming Ji, Wenbo Zhao, Sijie Li, Guiyou Liu
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 17:43Santagata Davide: Can Targeting Inflammation Help Prevent Thrombosis?
-
Oct 30, 2026, 17:38Patrick Ellsworth: Supporting Patients and Families Through Bleeding Disorders Awareness and Community Initiatives
-
Oct 30, 2026, 17:33Ed Shovelin: Comparative Hemostatic Performance of CRP-A and Equine Fibrillar Collagen
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management